Largest biotech by net assets

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

ImmunityBio has the lowest figure of the 24 biotech ranked by net assets, at -A$745.1M, followed by Halozyme Therapeutics (A$72.7M) and Kodiak Sciences (A$234.3M). Figures as of 18 Nov 2026, 16:06 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
Lowest
ImmunityBio-A$745.1M
Median
A$3B
Combined market value
A$1.25T
Countries
5

Market values as of .

Largest biotech by net assets
#CompanyNet assets ↑Market capPriceToday1 yearPrice, 30 daysCountry
1ImmunityBioIBRX · Health Care-A$745.1MA$10.5BA$9.85 5.67% up 193% up United States
2Halozyme TherapeuticsHALO · Health CareA$72.7MA$16.5BA$145.08 1.54% up 37% up United States
3Kodiak SciencesKOD · Health CareA$234.3MA$9.4BA$144.00 0.08% down 396% up United States
4Adaptive BiotechnologiesADPT · Health CareA$325.7MA$6.9BA$42.54 0.28% up 88% up United States
5Scholar Rock HoldingSRRK · Health CareA$365.5MA$8.6BA$70.72 5.37% up 14% up United States
6Twist BioscienceTWST · Health CareA$704.1MA$11.8BA$172.45 3.42% up 340% up United States
7CG OncologyCGON · Health CareA$1.1BA$10.6BA$118.57 0.89% up 85% up United States
8ImmunovantIMVT · Health CareA$1.3BA$10.4BA$50.13 1.39% up 43% up United States
9Krystal BiotechKRYS · Health CareA$1.8BA$13.7BA$460.78 3.67% up 46% up United States
10Kymera TherapeuticsKYMR · Health CareA$2.4BA$15.3BA$179.58 0.74% down 87% up United States
11Revolution MedicinesRVMD · Health CareA$2.4BA$51.5BA$238.28 1.62% down 131% up United States
12CRISPR TherapeuticsCRSP · Health CareA$2.9BA$6BA$61.74 3.29% up 21% down Switzerland
13RepligenRGEN · Health CareA$3.1BA$16.4BA$256.82 6.36% up 5% up United States
14Bio-TechneTECH · Health CareA$3.1BA$17BA$108.29 0.14% up 26% up United States
15ExelixisEXEL · Health CareA$3.2BA$25.1BA$102.76 0.76% up 63% up United States
16VaxcytePCVX · Health CareA$4BA$13.8BA$87.17 1.43% down 22% up United States
17Neurocrine BiosciencesNBIX · Health CareA$4.8BA$24.5BA$242.54 1.81% down 20% up United States
18QiagenQGEN · Health CareA$5.6BA$15.2BA$73.83 0.32% down 12% up Netherlands
19argenxARGX · Health CareA$10.9BA$88.8BA$1,411.70 0.07% up 4% up Belgium
20ModernaMRNA · Health CareA$12.9BA$121.7BA$300.84 2.29% down 755% up United States
21AmgenAMGN · Health CareA$12.9BA$360.5BA$666.56 2.23% down 34% up United States
22BiogenBIIB · Health CareA$27.2BA$55.1BA$372.79 0.16% down 49% up United States
23BioNTechBNTX · Health CareA$31.8BA$31.1BA$125.43 0.72% down 16% down Germany
24Gilead SciencesGILD · Health CareA$33.8BA$311.8BA$251.38 0.83% down 33% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 1.4888 AUD).

Questions and answers

Which biotech have the lowest net assets?

ImmunityBio (-A$745.1M), Halozyme Therapeutics (A$72.7M) and Kodiak Sciences (A$234.3M) have the lowest net assets of the 24 biotech ranked here as of 18 Nov 2026, 16:06 UTC.

How many biotech are in this ranking?

24 are ranked by net assets.

What are these biotech worth together?

The 24 biotech ranked by net assets have a combined market value of A$1.25T as of 18 Nov 2026, 16:06 UTC.

What does ranking by net assets measure?

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

Cite this page

Funkfolio, “Largest biotech by net assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=net-assets

Underlying data: Yahoo Finance; SEC EDGAR.